Conference Abstract

Utilization, User Characteristics, and Adverse Outcomes of Insulin Glargine Originators and Follow-on Drug in Patients with Diabetes in the US

38th Annual International Society for Pharmacoepidemiology Conference
August 1, 2022
Authors:

Rai A, Nam YH, Mendelsohn AB, Marshall J, McDermott CL, Toh S, Lockhart CM

Expertise:
RWE Research & Consulting
Home
Publications
Utilization, User Characteristics, and Adverse Outcomes of Insulin Glargine Originators and Follow-on Drug in Patients with Diabetes in the US
...

Poster presented at the 38th Annual International Society for Pharmacoepidemiology Conference

View the Poster
CONTACT US

© Real-World Evidence Practice. All rights reserved.

Harvard Pilgrim Health Care Institute Department of Population Medicine
Privacy Policy